1. Efficacy of pembrolizumab for patients with both high PD‐L1 expression and an MET exon 14 skipping mutation: A case report. Issue 2 (2nd January 2019) Authors: Baba, Keisuke; Tanaka, Hisashi; Sakamoto, Hiroaki; Shiratori, Toshihiro; Tsuchiya, Junichiro; Ishioka, Yoshiko; Itoga, Masamichi; Taima, Kageaki; Tasaka, Sadatomo Journal: Thoracic cancer Issue: Volume 10:Issue 2(2019) Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Performance of Japanese patients in registrational studies. (23rd November 2021) Authors: Goto, Yasushi; Arakawa, Sayaka; Shirasawa, Masayuki; Higashiyama, Ryoko; Baba, Keisuke; Masuda, Ken; Shinno, Yuki; Matsumoto, Yuji; Okuma, Yusuke; Yoshida, Tatsuya; Horinouchi, Hidehito; Yamamoto, Noboru; Ohe, Yuichiro Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 1(2022) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rapid development of pulmonary Mycobacterium avium infection during chemoradiotherapy followed by durvalumab treatment in a locally advanced NSCLC patient. (March 2021) Authors: Baba, Keisuke; Yoshida, Tatsuya; Shiotsuka, Mika; Kobayashi, Osamu; Iwata, Satoshi; Ohe, Yuichiro Journal: Lung cancer Issue: Volume 153(2021) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗